News tagged with medical oncology
Related topics: patients , breast cancer , cancer , lung cancer , cancer cells
The protein survivin could be a useful biomarker for pancreatic cancer
Pancreatic cancer kills more than 40,000 people every year, and among cancers it's particularly insidious. For 80 percent of patients, the disease is already so advanced at the time of diagnosis that treatment is unlikely ...
Cancer
Apr 01, 2012 |
not rated yet |
0
Protein Aurora-A is found to be associated with survival in head and neck cancer
Researchers at Fox Chase Cancer Center in Philadelphia have found that a protein associated with other cancers appears to also be important in head and neck cancer, and may consequently serve as a good target for new treatments. ...
Cancer
Apr 01, 2012 |
not rated yet |
0
Early clinical data show galeterone safe, effective against prostate cancer
Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
Noninvasive imaging can detect mutations within a brain tumor
Researchers at Winship Cancer Institute have developed a technique for detecting an "oncometabolite", a chemical produced by some brain tumors' warped metabolism, via non-invasive imaging.
Cancer
Mar 22, 2012 |
not rated yet |
0
|
New genomic test spares patients chemotherapy with no adverse effect on survival
Testing a breast cancer tumour for its genomic signature can help identify which patients will need adjuvant systemic therapy (additional chemotherapy) after surgery, and spare its use in those for whom it is not necessary, ...
Cancer
Mar 22, 2012 |
not rated yet |
0
Low bone density medications may have protective effect on endometrial cancer
Low bone density medications, such as Fosamax, Boniva and Actonel, may have a protective effect for endometrial cancer, according to a study at Henry Ford Hospital.
Cancer
Mar 21, 2012 |
not rated yet |
0
BIM gene variation in East Asians found to explain resistance to cancer drugs
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Cancer
Mar 18, 2012 |
not rated yet |
0
|
Study shows dry storage a viable option for biospecimens
(Medical Xpress) -- A University of Colorado Cancer Center pilot study has discovered that the quality of dehydrated RNA from human cancer biospecimens compares favorably to those stored in ultra-low-temperature ...
Cancer
Mar 05, 2012 |
not rated yet |
0
What causes cancer?
(Medical Xpress) -- Fears that involuntary exposure to chemicals in food and consumer products causes cancer are not supported by evidence, and anxiety about their dangers is diverting attention from proven methods of cancer ...
Cancer
Feb 28, 2012 |
5 / 5 (2) |
1
|
Latest advance in precise radiation treatment a powerful addition -- first in the nation
UT Southwestern Medical Center has installed a new system to deliver extremely precise and individualized radiation treatment, assuring that cancer patients in the region have access to the latest advances ...
Cancer
Feb 14, 2012 |
not rated yet |
0
First prospective clinical trial of adaptive radiotherapy for head and neck cancer patients
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy ...
Cancer
Feb 09, 2012 |
5 / 5 (1) |
0
Cirrhosis patients losing muscle mass have a higher death rate
Medical researchers at the University of Alberta reviewed the medical records of more than 100 patients who had a liver scarring condition and discovered those who were losing muscle were more apt to die while waiting for ...
Diseases, Conditions, Syndromes
Feb 07, 2012 |
not rated yet |
0
Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival
Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind ...
Cancer
Jan 12, 2012 |
not rated yet |
0
Sensitive detection method analyzes circulating tumor cells in patients with lung cancer
Researchers have developed a method to analyze circulating tumor cells in the blood of patients with non-small cell lung cancer. This method, which can analyze a sample size as small as three cells, may allow clinicians to ...
Cancer
Jan 09, 2012 |
not rated yet |
0
Enzyme that flips switch on cells' sugar cravings could be anti-cancer target
Cancer cells tend to take up more glucose than healthy cells, and researchers are increasingly interested in exploiting this tendency with drugs that target cancer cells' altered metabolism.
Cancer
Dec 22, 2011 |
not rated yet |
0
|
